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The Chinese medicine herb pair Flos Lonicerae japonicae (FLJ) and Forsythiae fructus (FF), is a representative
heat-clearing (qing re) and detoxifying (jie du) combination that exhibits many pharmacological activities, including
antibacterial, antiviral, antitumor, anti-inflammatory, and antioxidant effects. Extensive phytochemical studies have
identified a series of bioactive compounds, such as chlorogenic acid from FLJ and forsythoside A from FF. This
article provides a comprehensive review on the chemical and pharmacological principles of the traditional functions
of FLJ-FF, and sheds light on further developments of this herb pair.Introduction
Although Chinese medicine (CM) often uses multicom-
ponent formulations and the actions of each component
on multiple targets [1], the use of herb pairs—the unique
clinical combination of two relatively fixed herbs—is the
simplest and most fundamental form of multiherb therapy
aimed at specific efficacy. The role of herb pairs has been
explained by the yin and yang and five-phase theories [2],
and by reference to the broader philosophical and cultural
frameworks that emphasize balance between bodily func-
tions and environmental conditions [3]. Herb pairs are
simpler in composition than complete formulae but still
therapeutically effective. There are several aims and prin-
ciples of herbal compatibility, sometimes called the “seven
relations of CM”: singular application, mutual promotion,
mutual assistance, mutual restraint, mutual detoxification,
mutual inhibition, and mutual intoxication [4]. The
principle of mutual promotion explains why herb pairs
have significantly better pharmacological efficacy than in-
dividual herbs, a principle that is applied in many famous
herb formulae, such as Yinqiao San [1]. Recent pharmaco-
logical investigation has clarified this mutual effect [5].
The herb pair of Flos Lonicerae japonicae (FLJ) and For-
sythiae fructus (FF) has been widely used to cure febrile
illness (e.g., cold and flu) at the primary stage [6]. FLJ is
the flower bud of Lonicera japonica Thunb and FF is the
dried fruit of Forsythia suspensa. Yinqiao San, which* Correspondence: ligenl@umac.mo; ytwang@umac.mo
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used for detoxification and relieving internal heat and
fever [7]. Nowadays, the various available dosage forms of
FLJ-FF herb pair, such as capsules, powder, oral decoc-
tions, and granules, are mainly indicated for cold, fever,
and even upper respiratory tract infection [8]. The most
familiar ones are Vc Yinqiao tablet and Shuanghuanglian
oral decoction [9]. However, the mechanisms of the
formulae have not been completely elucidated, and re-
search on this combination has rarely been summarized.
This article aims to provide a comprehensive and up-to-
date review of phytochemical and pharmacological studies
of FLJ and FF.Review
Ethnopharmacological use of the Yinqiao herb pair
The FLJ-FF herb pair is described as light (qing) and
floating (fu), and able to clear heat, combat swelling, and
cure boils [10, 11]. It has been widely used as an antipyretic,
antidotal, and anti-inflammatory agent for the treatment of
infections such as acute nephritis and erysipelas.Chemical constituents of FLJ and FF
More than 140 compounds have been isolated from FLJ,
including flavonoids, iridoids, organic acids, and saponins.
Compounds identified from FLJ are listed in Table 1, in-
cluding chlorogenic acid, luteolin, loganin, and lonicero-
side A. One kind of important chemical component of FLJ
is its volatile oil; hexadecanoic acid, octadecadienoic acid,
ethyl palmitate, and dihydrocarveol are the main fattyle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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Table 1 Chemical constituents of Lonicera japonica Thunb
No. Compounds Resource Ref.
Organic acids
1 chlorogenic acid Whole plant [39]
2 isochlorogenic acid Whole plant [39]
3 caffeic acid Flower [57]
4 hexadecanoic acid Whole plant [60]
5 myristic acid Whole plant [60]
6 3,5-O-dicaffeoylquinic acid Whole plant [61]
7 4,5-O-dicaffeoylquinic acid Whole plant [61]
8 3,4-O-dicaffeoylquinic acid Whole plant [61]
9 1,3-O-dicaffeoylquinic acid Whole plant [61]
10 3-ferulicoylquinic Whole plant [61]
11 4-ferulicoylquinic Whole plant [61]
12 5-O-caffeoylquinic acid Whole plant [62]
13 4-O-caffeoylquinic acid Whole plant [62]
14 caffeoyl-CH2-O-quinic acid Whole plant [62]
15 1,5-O-dicaffeoylquinic acid Whole plant [62]
16 1,4-O-dicaffeoylquinic acid Whole plant [62]
17 methylated dicaffeoylquinic acid Whole plant [62]




19 3,5-O-dicaffeoylquinic acid Flower buds [63]
20 methyl chlorogenate Flower buds [63]
21 3-O-caffeoylquinic acid butyl ester Flower buds [64]
22 3-O-caffeoylquinic acid Flower buds [65]
23 3-caffeoylquinic acid methyl ester Flower buds [65]
24 3,5-dicaffeoylquinic acid butyl ester Flower buds [65]
25 vanillic acid 4-O-β-δ-(6-O-
benzoylglucopyranoside)
Flower buds [63]
26 protocatechuic acid Flowers [39]
27 chlorogenic acid butyl ester Flower buds [35]
28 chlorogenin tetraacetate Flower buds [66]
29 5-feruloylquinic acid Aerial Parts [67]
30 methyl 3,5-di-O-caffeoylquinic acid Whole plant [36]
31 methyl 3,4-di-O-caffeoylquinic acid Whole plant [36]
32 caffeic acid methyl ester Whole plant [37]
Flavonoids
33 chrysoeriol Flowers [57]
34 chrysoeirol-7-O-neohesperidoside Aerial parts [57]
35 luteolin Flowers [57]
36 chrysoeriol 7-O-β-δ-glucopyranoside Flowers [57]
37 isorhamnetin 3-O-β-δ-glucopyranoside Flowers [57]
38 isorhamnetin 3-O-β-δ-rutinoside Flowers buds [35]
39 kaempferol 3-O-β-δ-glucopyranoside Flowers [57]
40 kaempferol 3-O-β-δ-rutinoside Flowers buds [35]
Table 1 Chemical constituents of Lonicera japonica Thunb
(Continued)
41 quercetin 3-O-β-δ-glucopyranoside Flowers [68]
42 luteolin 7-O-α-δ-glucoside Flowers [68]
43 luteolin-7-O-β-δ-galactoside Flowers [68]
44 hyperoside Aerial parts [69]
45 lonicerin Whole plant [70]
46 hydnocarpin Aerial parts [71]
47 quercetin Aerial parts [71]
48 astragalin Aerial parts [71]
49 isoquercitrin Aerial parts [71]
50 rhoifolin Aerial parts [71]
51 flavoyadorinin-B Aerial parts [63]
52 rutin Flowers buds [64]
53 tricin-7-O-β-d-glucoside Flowers buds [64]
54 chrysin Leaves [72]
55 eriodictyol Aerial parts [69]
56 apigenin Aerial parts [69]
57 corymbosin Aerial parts [60]
58 5-hydroxy-3, 4,7-trimethoxylflavone Aerial parts [60]
59 ochnaflavone Whole plant [71]
60 ochnaflavone 4′-O-methyl ether Aerial parts [71]
Iridoids
61 loganin Whole plant [70]
62 sweroside Flower buds [73]
63 7-O-ethyl sweroside Flower buds [74]
64 7-epivogeloside Flower buds [74]
65 secoxyloganin Flower buds [74]
66 secoxyloganin 7-butyl ester Flower buds [74]
67 7-dimethyl-secologanoside Flower buds [74]
68 centauroside Flower buds [74]
69 secologanic acid Flower buds [62]
70 secologanin Flower buds [73]
71 secologanin dimethyl acetal Flower buds [73]
72 kingiside Flower buds [75]
73 vogeloside Flower buds [76]
74 epi-vogeloside Flower buds [76]
75 dehydrormorroniside Flower buds [77]
76 ketologanin Flower buds [78]
77 7α-morroniside Flower buds [78]
78 7β-morroniside Flower buds [78]
79 secologanoside Flower buds [78]
80 lonijaposide A Flower buds [78]
81 lonijaposide B Flower buds [78]
82 lonijaposide C Flower buds [78]
83 lonijaposide D Flower buds [78]
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(Continued)
84 lonijaposide E Flower buds [78]
85 lonijaposide F Flower buds [78]
86 lonijaposide G Flower buds [78]
87 lonijaposide H Flower buds [78]
88 lonijaposide I Flower buds [78]
89 lonijaposide J Flower buds [78]
90 lonijaposide K Flower buds [78]
91 lonijaposide L Flower buds [78]




94 6′-O-(7α-hydroxyswerosyloxy) loganin Stems,leaves [79]
95 (Z)-aldosecologanin Stems,leaves [79]
96 (E)-aldosecologanin Stems,leaves [79]
97 loniceracetalide A Flower buds [76]






















xylpyranosyl (1→ 6)-β-d-glucopyranosyl ester
Flower buds [66]






























110 loniceroside A Whole plant [75]
111 loniceroside B Whole plant [75]
112 loniceroside C Aerial parts [82]
113 loniceroside D Flower buds [83]
114 loniceroside E Flower buds [83]
115 macranthoidin A Flower buds [64]
116 macranthoidin B Flower buds [64]




119 macranthoside B Flower buds [64]




122 saponin 1 Flower buds [62]
123 saponin 4 Flower buds [62]
124 hederagenin 3-O-α-l-arabinopyranoside Flowers [57]
125 hederagenin Whole plant [70]
126 oleanolic acid Flower buds [35]
Others
127 lonijaposide A1 Flowers [72]
128 lonijaposide A2 Flowers [72]
129 lonijaposide A3 Flowers [72]
130 lonijaposide A4 Flowers [72]
131 lonijaposide B1 Flowers [72]
132 lonijaposide B2 Flowers [72]
133 5-hydroxymethyl-2-furfural Flowers [57]
134 1-O-methyl-myo-inositol Flower buds [35]
135 nonacontane Flower buds [35]
136 β-sitosterol Flower buds [35]
137 sucrose Flower buds [35]
138 glucose Flower buds [35]







142 5′-O-methyladenosine Flower buds [78]
143 guanosine Flower buds [78]
144 adenosine Flower buds [78]
145 syringin Flower buds [78]
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Table 2 Chemical constituents of Forsythiae fructus
No. Compounds Ref.
Phenylethanoid Glycosides
146 forsythoside A [84]
147 forsythoside B [85]
148 forsythoside C [85]
149 forsythoside D [85]
150 forsythoside E [86]
151 forsythoside F [86]
152 isoforsythoside [87]
153 forsythoside H [86]
154 forsythoside I [86]
155 forsythoside J [86]
156 R-forsythoside J [88]
157 S-forsythoside J [88]
158 R-suspensaside [88]
159 S-suspensaside [88]
160 S-suspensaside methyl ether [88]
161 calceolarioside A [89]
162 calceolarioside B [86]
163 plantainoside A [89]
164 suspensaside A [90]
165 lianqiaoxinoside B [54]
166 salidroside [91]
167 3,4-dihydroxyphenyl alcohol-8-o-β-D-glucopyranoside [90]
168 forsythenside A [35]





171 isobauerenyl acetate [90]
172 ocotillone [90]
173 ocotillol acetate [90]
174 20(S)-dammar-24-ene-3β,20-diol-3-acetate [92]
175 oleanolic acid [93]
176 β-amyrinacetate [92]
177 ursolic acid [93]
178 2α,3α-hydroxyursolic acid [94]
179 2α,23-hydroxyursolic acid [93]
180 betulinic acid [95]
181 3β-acetylbetulinic acid [95]
182 2α-hydroxybetulinic acid [93]
183 3β-acetyl-20,25-epoxydammarane-24α-ol [96]
184 3β-acetyl-20,25-epoxydammarane-24β-ol [96]
185 onjisaponin F [94]
186 onjisaponin G [94]
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trometry [12].
More than 100 compounds have been identified from
FF, including alkaloids, flavonoids, phenylethanoid gly-
cosides, triterpenoids, and lignans (Table 2). The major
constituents of FF include quercetin, rutaecarpine, for-
sythiaside A, betulinic acid, and forsythialan A. According
to the China Pharmacopoeia (2005 edition), forsythin is a
chemical marker for quality control of FF. Recent pharma-
cological research indicates that forsythiaside, forsythin,
and rutin are responsible for the biological activities of FF
[13]. Thus, the use of forsythin as a single marker for FF
quality control is likely to lead to biased assessment.
Quantification of both forsythiaside and forsythin in FF is
important for the evaluation of this herb’s quality. In the
2010 edition of the China Pharmacopoeia, both forsythin
and forsythiaside were specified as FF quality control
markers.
Pharmacological effects
Forsythoside A has strong antioxidant, antibacterial, and
antiviral activities [14]. Forsythiaside exhibits strong
antibacterial, antiviral, antioxidant, anti-inflammatory,
and cyclic adenosine monophosphate phosphodiesterase
inhibitory effects [15]; forsythin and rutin show a strong
antioxidant effect [16]. In addition, chlorogenic acid
possesses antibacterial and antiviral activities [17]. The
bioactive properties of FLJ and FF are summarized
below in terms of traditional functions and modern
pharmacological findings.
Effects of the FLJ-FF herb pair
Studies of the synergistic action of the FLJ-FF herb pair
are rare. There is little evidence for its synergistic prop-
erties, although Li et al. [18] reported a synergistic anti-
inflammatory effect. They established a rat model of
chronic obstructive pulmonary disease and treated the
animals with FLJ-FF herb pair extract (FLJ:FF, 2:3) and a
single herb extract. FLJ-FF herb pair treatment improved
chronic obstructive pulmonary disease pathological
changes and significantly reduced interleukin-1β (IL-1β)
levels in bronchoalveolar lavage fluid compared with
each single herb. Duan et al. [19] evaluated anti-free
radical activity of the FLJ-FF herb pair using a rat fever
model. They divided Sprague–Dawley rats into different
groups, treated some groups with 20 % dilute yeast sus-
pension to create a fever model, and then tested the ef-
fectiveness of different drug combinations. The FLJ-FF
herb pair showed potent free radical cleavage activity.
Using microbial-plate methods, Wang et al. [20] found
the FLJ-FF herb pair at the ratio of 1:6 showed the most
significant inhibitory effect on Streptococcus suis 2.
These studies indicate that FLJ and FF show stronger
bioactivity in combination than alone.
Table 2 Chemical constituents of Forsythiae fructus (Continued)
Lignans
187 (−) arctigenin [97]
188 (−) dimethylmatairesinol [97]
189 (+) phillygenin [93]
190 (+) phillyrin (forsythin) [98]
191 (+) epipinoresinol [88]
192 (+) epipinoresinol-4-O-β-D-glucoside [98]




197 (+) pinoresinol [88]
198 (+) pinoresinol-β-D-glucoside [99]










209 benzenebutanoic acid [55]
210 olivil [97]
211 (+) lariciresinol [55]
212 forsythialan A [101]
213 forsythialan B [101]
Iridoid Glycosides




217 rengyoside A [91]
218 rengyoside C [91]
219 suspenol [84]
220 rengyolester [103]
221 rengynic acid [98]
222 rengynic acid 1′-O-β-D-glucoside [98]
223 rengyoxide [104]
224 rengyoside B [91]
225 rengyolone [91]
226 cornoside [104]
227 forsythenside B [90]













238 octahydro-1H, 5H-dipyrrolo [1,2-a:1′,2′-d] pyrazine [109]
Others
239 stearic acid [16]
240 palmitic acid [16]
241 vanillic acid [90]
242 caffeic acid [90]
243 4-methoxycaffeic acid [100]
244 chlorogenic acid [106]
245 4-caffeoylrutinose [98]
246 suspenolic acid [98]
247 3-ethyl-7-hydroxyphthalide [67]
248 forsythenin [90]
249 tannic acid [110]
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FF is a broad-spectrum antimicrobial agent used mainly
for upper respiratory tract infection and acute nephritis
[10, 11]. Previous studies have shown that the antibac-
terial ingredients of Forsythia species are concentrated
in lignans, phenylethanoid glycosides, and volatile oil.
Endo et al. [21, 22] investigated the antibacterial
principle of F. suspensa leaves, and found that forsytho-
sides A, B, C, and D showed antibacterial activity against
Staphylococcus aureus at <2 μM. In 2005, the effect of F.
suspensa volatile oil against Saccharomyces cerevisiae,
Penicillium chrysogenum, and Aspergillus niger was esti-
mated by paper dispersion method. The minimal bacteri-
cidal concentrations (MBC) were 3.91 × 10−4 mL/100 mL,
7.81 × 10−4 mL/100 mL, and 3.13 × 10−3 mL/100 mL,
respectively [23]. Chen’s group [11] investigated the thera-
peutic effect of FF ethanol extract on Salmonella typhi-
murium infection in mice. The survival rate of mice
treated by FF ethanol extract was higher than in the con-
trol group; the numbers of viable bacteria in spleen and
the spleen weight index were much lower in the treatment
group. Furthermore, the levels of immunoglobulin G and
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with the control group. The survival rate of the infected
mice was as high as 70 % when the therapeutic dose of FF
ethanol extract was 30 g/kg/day, which demonstrates a
significant relationship between input (dose) and output
(effect) (P < 0.05). All of the above studies support the
traditional use of FF as an antibacterial agent.
The antibacterial activity of FLJ has been comprehen-
sively studied. In 2009, Rahman et al. [12] evaluated the
antibacterial potential of FLJ volatile oil, which showed a
remarkable antibacterial effect against Listeria monocyto-
genes (ATCC 19116), Bacillus subtilis (ATCC 6633), Ba-
cillus cereus SCK 111, Staphylococcus aureus (ATCC
6538 and KCTC 1916), Salmonella enteritidis (KCTC
12021), Salmonella typhimurium (KCTC 2515), Entero-
bacter aerogenes (KCTC 2190), and Escherichia coli
(ATCC 8739). The inhibition zone diameters were 20.3,
17.8, 15.2, 16.3, 14.1, 15.3, 14.0, 12.4 and 12.1 mm, re-
spectively. The MIC values were 62.5, 62.5, 250, 125,
250, 125, 250, 500 and 500 μg/mL, respectively. These
findings suggest that FLJ volatile oil is a potential source
of preservatives for the food or pharmaceutical indus-
tries. The antibacterial activities of FLJ against Bacillus
cereus and Staphylococcus aureus were tested using the
agar-well diffusion method in vitro. The inhibition zone
diameters were 6.3 and 7.2 mm, respectively; this activity
might be closely associated with the existence of phenolic
constituents [24]. Moreover, FLJ exhibited marked anti-
bacterial activity against 14 strains, including Staphylo-
coccus aureus, Streptococcus haemolyticus, Escherichia
coli, Bacillus dysenteriae, Bacillus comma, Bacillus
typhosus, Bacillus paratyphosus, Pseudomonas aeruginosa,
Klebsiella pneumoniae, Bacillus tuberculosis, Streptococcus
mutans, Bacillus adhaerens, Bacteroides melaninogenicus,
and Haemophilus actinomycetemcomitans. FLJ extracts
have also been found to inhibit 87.5 % strains using
MIC 25 mg/mL [25].
One study investigated the antimicrobial activity of
FLJ water and alcohol extract. The MIC and MBC values
for the water extract on Staphylococcus aureus were
19.25 and 38.50 %, respectively; the MIC and MBC
values for the alcohol extract on Salmonella enteritidis
were 9.80 and 19.60 %, respectively, and for Staphylococ-
cus aureus were 19.60 and 39.20 %, respectively [26]. FLJ
flavonoids also showed a strong antibacterial action, es-
pecially for methicillin-resistant Staphylococcus aureus
(MIC ≤5 mg/mL) [27]. These reports suggest that FLJ is
a potent agent for treating various bacteria.
Detoxifying: antiviral activity
Several studies have demonstrated the antiviral activity of
FF. FF aqueous extract showed antiviral activity against re-
spiratory syncytial virus (RSV) with IC50 50 μg/mL and
CC50 1000 μg/mL [28]. Wen et al. found that 80 % ethanolextract of FF had a significant protective effect on Madin–
Darby canine kidney cells infected by the H1N1 virus in a
dose-dependent manner [29]. Li et al. [30] assessed the ef-
fects of forsythoside A on cell infection by avian infectious
bronchitis virus; the data indicated that this compound
prevented virus infection in vitro, but the mechanisms
remain unclear.
Many studies have disclosed antiviral activity of FLJ,
including anti-RSV, anti-HIV (human immunodeficiency
virus), and anti-NDV (Newcastle disease virus) effects.
Two studies used a cytopathologic effect (CPE) assay to
test the antiviral activities against RSV of 44 medicinal
herbs used for the treatment of respiratory tract infectious
diseases in China [28, 31]. FLJ showed potent antiviral
activity against RSV; the IC50 was 50.0 μg/mL and the
selectivity index was more than 20.0. FLJ extract and
chlorogenic acid had significant anti-cytomegalovirus
activity, and the 0 % toxic dose, minimum effective
concentration, and therapeutic index (TI) of these two
composites for human cytomegalovirus were 3000 μg/mL,
3000 μg/mL, 1 and 100 μg/mL, 1 μg/mL, 100, respectively
[32]. In in vitro tests, FLJ extract showed 104 and 72 times
the TI for anti-herpes simplex virus-1 F and anti-herpes
simplex-1 to acyclovir. Regarding the caviid beta-herpes
virus 1, FLJ showed significant inhibition of the duplica-
tion of guinea pig cytomegalovirus at the cell level; the
TI and the inhibitory duplication index were 100 and
2.61 μg/mL, respectively [33]. The anti-virus (H9N2)
and anti-avian influenza virus (least effective dose
[LED] = 3.90 mg/mL, in vitro) activities of FLJ flavones
have also been tested [34]. In Vero cells, three different
extracts of FLJ, including volatile oil (P1), chlorogenic
acids extract (P2), and flavones extract (P3), were tested
for antiviral activity against the pseudorabies virus
(PRV) and NDV. At doses of 232.7, 116.35, 58.18, and
29.09 μg/mL, the P1 interdiction rates for PRV and NDV
were 40.13 %, 17.83 %, 13.16 %, 2.24 % and 75.40 %,
32.01 %, 12.05 %, 2.34 % on the CPE, respectively, and
the LEDs of P1 for PRV and NDV were 232.7 and
232.7 μg/mL, respectively. The P2 interdiction rates
(3.125, 1.563, 0.781, and 0.391 mg/mL) for PRV and
NDV were 63.74 %, 46.27 %, 13.10 %, 3.51 % and
65.23 %, 36.71 %, 32.61 %, 28.96 % on the CPE, respectively.
The P3 interdiction rates (1.954, 0.977, 0.489, and
0.244 mg/mL) for PRV and NDV were 94.00 %, 78.42 %,
42.30 %, 3.36 % and 78.07 %, 27.63 %, 16.37 %, 6.73 %, re-
spectively. For P2 and P3, the LEDs against PRV were 0.997
and 3.097 mg/mL, respectively and against NVD, they were
0.781 and 1.563 mg/mL, respectively. These studies sug-
gest that FLJ extracts decrease CPE lesions and neutralize
viruses in a dose-dependent manner, inhibiting viruses
directly and promoting cell antivirus responses [35].
Several FLJ tannins have also been investigated; 3,5-di-
O-caffeoylquinic acid and methyl 3,5-di-O-caffeoylquinic
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scriptase (RT) and human DNA polymerase-α (HDNAP-
α) [36]. The IC50 ratio of these two compounds for HIV-1
RT and HDNAP-α was 2.0 and 2.2, respectively. 3,4-di-O-
caffeoylquinic acid and methyl 3,4-di-O-caffeoylquinic
acid exhibited higher inhibitory effects on HDNAP-α than
on HIV-1 RT [36]. Thirteen other caffeoylquinic acids
isolated from FLJ, including caffeic acid and caffeic acid
methyl ester, were also found to show antiviral activities
against respiratory viruses [37]. FLJ extract showed an
obvious therapeutic action on mice infected with influenza
A virus pneumonia [31]. The lung indexes of the FLJ
group and the ribavirin group were significantly lower
than in the model group, but there was no significance
difference between the two treatment groups. FLJ ex-
tract reduced histopathological changes, viral duplica-
tion, and the contents of influenza virus nucleic acid
compared with the model group. The tumor necrosis
factor-α (TNF-α) and IL-1β expressions of the FLJ and
the ribavirin groups were significantly lower than those
of the model group. The FLJ chemical principles for
antiviral activity were identified as chlorogenic acids,
flavones, tannins, and volatile oil [31].
Detoxifying: antitumor activity
The apoptosis mechanisms induced by photodynamic
therapy (PDT) in lung CH27 carcinoma cells, cultured
with FLJ alcohol extract as a photosensitizer, have been ex-
plored. This extract exhibited significant photocytotoxicity
in CH27 cells at a concentration range of 50–150 μg/mL,
with light doses of 0.4–1.2 J/cm2. Apoptosis induced by
PDT combined with FLJ extract was accompanied by
DNA condensation, externalization of phosphatidylser-
ine, and formation of apoptotic bodies [38]. The p38-
associated pathway might be involved in apoptosis
induced by PDT with FLJ in CH27 cells. In another
study, FLJ extract induced CH27 cell apoptosis via protein
expression change and distribution of heat shock protein
27. Treatment with FLJ aqueous extract (100 μg/mL) was
associated with increased stimulatory phosphorylation of
c-Jun amino-terminal kinase and p38 in HepG2 cells,
similar to the mitogen-activated protein kinase activation
profile of protocatechuic acid [39]. This aqueous extract
also decreased the viability of HepG2 cells to 50 % and
triggered HepG2 cell death in a c-Jun amino-terminal
kinase-dependent manner.
Heating clearing: anti-inflammatory activity
Inflammation prevents infection through production of
pro-inflammatory cytokines and generation of inflamma-
tory mediators in response to microbial products [40].
Dysregulation of inflammation has an adverse effect on
the body. Although modern anti-inflammatory drugs
can bring relief, new kinds of microorganisms and theemergence of drug-resistant strains have resulted in sig-
nificant morbidity and mortality. In the past few decades,
more attention has been focused on the anti-inflammatory
effect of CM herbs, especially heat-clearing herbs [41].
Many studies have demonstrated the anti-inflammatory
action of FF. FF was found to exhibit platelet-activating
factor antagonistic activity and inducible nitric oxide syn-
thase inhibitory activity [42]. An FF methanol extract and
its hexane fraction showed anti-inflammatory and anal-
gesic activity against carrageenan-induced edema, cotton
pellet-induced granuloma, and acetic acid-induced vascu-
lar permeability [43]. FF extract inhibited 5-lipoxygenase
and elastase with the same IC50 values of 80 μg/mL [44].
FF ethanol extract also inhibited the secretion of the
cytokine RANTES from virus-infected human bronchial
epithelial cells [45]. These findings suggest that FF pos-
sesses anti-inflammatory activity through multiple target
signaling pathways and multiple mechanisms of action.
Both in vivo and in vitro studies have shown that FLJ
extract can inhibit various inflammatory reactions and
suppress various inflammatory factors. Xu et al. [46]
evaluated the anti-inflammatory property of FLJ aqueous
extract in A549 cells; the extract directly inhibited both
COX-1 and COX-2 activity, and IL-1-induced expression
of COX-2 protein and mRNA. Kang et al. [47] examined
the effect of FLJ water fraction on trypsin-induced mast
cell activation. After stimulation with trypsin (100 μM),
FLJ water fraction inhibited TNF-α secretion, tryptase
mRNA expression, and trypsin-induced extracellular
signal-regulated kinase phosphorylation in a dose-
dependent manner; however, it did not affect trypsin ac-
tivity even at 1000 μg/mL. These studies indicate that
FLJ might inhibit trypsin-induced mast cell activation
through the inhibition of extracellular signal-regulated
kinase phosphorylation rather than by inhibition of tryp-
sin activity. One study evaluated the anti-inflammatory
activity of n-butanol (4.2 % based on the dry weight
[DW]) FJL fraction [48]. At a 400 mg/kg oral dose, it
showed significant anti-inflammatory activities against
arachidonic acid ear edema, croton-oil ear edema, carra-
geenan paw edema, and rat cotton pellet granulomatous
and adjuvant-induced arthritis inflammation models in
mice and rats; the inhibition rates were 27 %, 23 %,
26 %, 18 %, and 42 %, respectively and the inhibition
rates for the positive drug aspirin (100 mg/kg) were
27 %, 13 %, 13 %, 0 %, and 58 %, respectively.
FLJ water extract showed an anti-inflammatory effect on
proteinase activated receptor 2 (PAR2)-mediated mouse
paw edema; at doses of 50, 100, and 200 mg/kg, it sig-
nificantly inhibited paw thickness change and vascular
permeability induced by PAR2 (inhibition rates: 41.8 %,
69.1 %, 70.9 %, and 40.2 %, 69.7 %, 68.8 %, respectively).
FLJ water extracts (100 mg/kg) also significantly inhibited
PAR2 agonist-induced myeloperoxidase (MPO) activity
Guo et al. Chinese Medicine  (2015) 10:16 Page 8 of 11and TNF-α expression in paw tissue [49]. Tae et al. [50]
used the supercritical CO2 extraction process to obtain
1.08 % volatile oil from FLJ; pharmacological studies
suggested a potent anti-inflammatory effect of the vola-
tile oil on the ear-swelling model in mice. These reports
indicate that FLJ is a safe, mild anti-inflammatory agent
for treating various inflammatory disorders.
Heat clearing: antioxidant activity
Excessive reactive oxygen species result in significant
damage to biological structures necessary to cellular integ-
rity and survival. CM heat-clearing herbs are an important
source of antioxidant agents. A study using a 1-diphenyl-
2-picrylhydrazyl (DPPH) free radical scavenging experi-
ment found that the CH2Cl2 fraction of F. suspensa
exerted the strongest scavenging activity and suggested
that forsythialan A and phillygenin F are the major anti-
oxidant constituents [51, 52]. Zhang et al. [53] studied the
role of forsythoside A in the elimination of reactive oxygen
species and discussed the relationship between structure
and activity using quantum chemical calculation. The
results showed that the A and B rings in forsythoside A
were active parts of its antioxidant activity, and the
structure of phenolic hydroxyl groups in opposition
caused higher antioxidant activity. Moreover, lianqiaox-
inoside B and forsythoside H showed nearly the same
antioxidant activities. These phenylethanoid glycosides
have two ortho-substituting hydroxyl groups in both
the caffeoyl and phenylethanoid moieties, which could
be an important factor in their high antioxidant activity
[54]. Lignans obtained from FF could protect human
high-density lipoprotein against lipid peroxidation. In
one study, they inhibited the generation of thiobarbitu-
ric acid-reactive substances in a dose-dependent man-
ner with IC50 values from 8.5 to 18.7 μM. Among these
lignans, some exerted an inhibitory effect against the
Cu2+-induced lipid peroxidation of high-density lipo-
protein, as shown by an extended lag time prolongation
at a 3.0 μM concentration [55]. The protective activity
of F. suspensa against peroxynitrite (ONOO)-induced
cellular damage was investigated, and its active compo-
nents, phillygenin and 8-hydroxypinoresinol, were identi-
fied. These two compounds significantly reduced cell
injury by 3-morpholinosydnonimine, an ONOO generator.
The hydroxyl substituents of these lignans on the phenyl
moieties may contribute to the antioxidant activity [56].
The antioxidant action of FLJ has been widely investi-
gated. The FLJ ethyl acetate fraction exhibited marked scav-
enging/inhibitory activities with IC50 values of 4.37, 27.58 ±
0.71, 0.47 ± 0.05, and 12.13 ± 0.79 μg/mL in the DPPH rad-
ical, total reactive oxygen species, hydroxyl radical (−OH),
and peroxynitrite (ONOO−) assays, respectively [57]. The
main compounds of the ethyl acetate fraction—luteolin,
caffeic acid, protocatechuic acid, and luteolin 7-O-d-glucopyranoside—also evidenced marked scavenging activ-
ities, with IC50 values of 2.08–11.76 μM for DPPH and
1.47–6.98 μM for ONOO− [57]. The Trolox equivalent
antioxidant capacity values and total phenolic content for
methanolic extracts of FLJ have been demonstrated as
589.1 μmol Trolox equivalent/100 g DW and 3.63 gallic
acid equivalent/100 g DW [58]. These studies suggest that
FLJ is a potential natural antioxidant and beneficial chemo-
preventive agent. The antioxidant activity of polysaccha-
rides with different molecule weights separated from FLJ by
ultrafiltration was also studied. The reducing power of the
polysaccharides had a direct correlation with antioxidant
activity and concentration of certain plant extracts, and the
ultrafiltration fraction had a significant inhibitory effect on
superoxide radicals generated in a phenazine methosul-
phate/hydrogenated nicotinamide adenine dinucleotide/
nitroblue tetrazolium system. Administered to rats, crude
polysaccharide extracts (50–400 mg/kg) were found to re-
duce lipid peroxidation malondialdehyde content, improve
glutathione peroxidase and catalase activity, and signifi-
cantly enhance superoxide dismutase activity in serum and
tissue [59].
Limitations of this review
Few studies demonstrated a synergistic or additive effect
for this herb pair. Comparable studies, using both single
herbs (FLJ and FF) and the FLJ-FF herb pair, should be
conducted to investigate possible synergistic or additive
effects. Interdisciplinary research is needed to identify
minor bioactive components using phytochemical stud-
ies, to generate reliable cell and animal models using
pharmacological studies, and to elucidate underlying
mechanisms using molecular biological studies.
All pharmacological studies reviewed here used in vitro
or in vivo models; there was no clinical investigation of
the effects of the FLJ-FF herb pair (or of single herbs).
Thus, this review provides no clinical evidence for the bio-
activities of FLJ and FF. In addition, some of the pharma-
cological targets of the FLJ-FF herb pair are still unknown.
Conclusion
The main bioactive components of FLJ and FF are flavo-
noids, organic acids, volatile oil, phenylethanoid glyco-
sides, lignans, and triterpenoids. These show clear
pharmacological effects, including antibacterial, antiviral,
anti-inflammatory, antitumor, and antioxidant actions.
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